Search results for "DIABETES MELLITUS"

showing 10 items of 2077 documents

Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes.

2021

Abstract Background and aim To study the association between achievement of guideline-defined treatment targets on HbA1c, low-density lipoproteins (LDL-C), and blood pressure with the progression of diabetic complications in patients with type 1 diabetes (T1D). Methods The study included 355 patients at baseline and 114 patients with follow-up data after 3–5 years. Outcome variables were the progression of diabetic kidney disease, retinopathy, or cardiovascular disease (CVD). We used logistic regression and other machine learning algorithms (MLA) to model the association of achievement of treatment targets and probability of progression of complications. Results Achievement of the target bl…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismDiseaseLogistic regressionOddsDiabetes ComplicationsMachine LearningEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansDiabetic NephropathiesGlycated HemoglobinType 1 diabetesbusiness.industryCholesterol LDLMiddle Agedmedicine.diseaseLatviaBlood pressureDiabetes Mellitus Type 1Treatment OutcomeCardiovascular DiseasesHypertensionDisease ProgressionComplicationbusinessRetinopathyFollow-Up StudiesJournal of diabetes and its complications
researchProduct

Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily.

2019

Objective To better characterize the metabolic alterations in various phenotypes of polycystic ovary syndrome (PCOS) in a large homogeneous (Sicilian) Mediterranean population with a low prevalence of obesity. Design Retrospective study. Patients A total of 1215 consecutively evaluated women with PCOS divided into four Rotterdam phenotypes (A, B, C and D) and in 108 matched ovulatory, nonhyperandrogenic women. Measurements BMI, fasting glucose, total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol and an oral glucose tolerance test. Results The overall prevalence of obesity was 31%, metabolic syndrome 6.6%, diabetes 2.1%, altered glucose metabolism 13.1%, and abnormal lipid pro…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulation030209 endocrinology & metabolismCarbohydrate metabolism03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicinemedicineHumanseducationSicilyTriglyceridesRetrospective Studieseducation.field_of_studybusiness.industryCholesterolCholesterol HDLCholesterol LDLGlucose Tolerance Testmedicine.diseasePolycystic ovaryPhenotypeObesityEndocrinologychemistry030220 oncology & carcinogenesisFemaleMetabolic syndromebusinessPolycystic Ovary SyndromeClinical endocrinologyREFERENCES
researchProduct

Serum magnesium and lipids: More clarity is needed

2007

Adultmedicine.medical_specialtyMagnetic Resonance SpectroscopyDiabetes; Lipids; Magnesium; Obesitychemistry.chemical_elementDiabeteInternal medicineDiabetes mellitusHumansMedicineMagnesiumObesityLdl cholesterolbusiness.industryMagnesiumCholesterol HDLDiabetesCholesterol hdlCholesterol LDLLipidmedicine.diseaseLipidsObesityEndocrinologyDiabetes Mellitus Type 2chemistryDiabetes; Lipids; Magnesium; Obesity; Adult; Cholesterol HDL; Cholesterol LDL; Diabetes Mellitus Type 2; Humans; Magnesium; Magnetic Resonance Spectroscopy; Cardiology and Cardiovascular MedicineCardiology and Cardiovascular MedicinebusinessHuman
researchProduct

Maternal-fetal Complications in Pregnancy: A Retrospective Comparison Between Type 1 and Type 2 Diabetes Mellitus

2021

Abstract Background The aim of the study was a retrospective comparison of the differences in maternal-foetal outcomes between women with type 1 and type 2 diabetes mellitus (T1DM and T2DM). Methods A cohort of 135 patients with pregestational diabetes, 73 with T1DM (mean age 29 ± 5 years) and 62 with T2DM (mean age 33 ± 6 years), in intensive insulin treatment throughout pregnancy were evaluated. Clinical and metabolic parameters and the prevalence of maternal and foetal complications were assessed. Results Women with T1DM showed lower pregestational BMI (p < 0.001), pregestational weight (p < 0.001), weight at delivery (p < 0.001), ∆_total_insulin requirement (IR) at the first, s…

Adultmedicine.medical_specialtyMultivariate analysisendocrine system diseasesmedicine.medical_treatmentReproductive medicine030209 endocrinology & metabolismAbortionMacrosomialcsh:Gynecology and obstetricsBody Mass IndexFetal Macrosomia03 medical and health sciencesYoung Adult0302 clinical medicinePregnancyRisk FactorsInsulin requirementmedicinePrevalenceHumansInsulinlcsh:RG1-991Retrospective StudiesGlycated HemoglobinPregnancy030219 obstetrics & reproductive medicineObstetricsbusiness.industryInsulinAbortionObstetrics and GynecologyType 2 Diabetes Mellitusnutritional and metabolic diseasesmedicine.diseaseGestational Weight GainAbortion SpontaneousDiabetes Mellitus Type 1Diabetes Mellitus Type 2Large for gestational ageCohortFemalePregnancy Trimestersmedicine.symptomInsulin ResistancebusinessWeight gainResearch Article
researchProduct

Liver disease as risk factor for cystic fibrosis-related diabetes development

2007

Aim: To evaluate clinical and genetic factors, besides pancreatic insufficiency, associated with increased risk of cystic fibrosis-related diabetes. Methods: Case-control (1:1) study on 138 cystic fibrosis patients. Data were collected on gender, age at diagnosis, reason for cystic fibrosis diagnosis, family history of type 1 or 2 diabetes mellitus, pre-existing severe liver disease, and class of cystic fibrosis transmembrane regulation mutation. Moreover, information was obtained on lung involvement and degree of exocrine pancreatic insufficiency evaluated 1 year before the diagnosis of cystic fibrosis-related diabetes in patients and age-matched controls. Results: Compared to controls, pa…

Adultmedicine.medical_specialtyPathologyPancreatic diseaseAdolescentCystic FibrosisCystic fibrosis-related diabetesComorbidityGastroenterologyCystic fibrosisLiver diseaseRisk FactorsInternal medicineDiabetes mellitusmedicineDiabetes MellitusHumansRisk factorExocrine pancreatic insufficiencybusiness.industryLiver DiseasesGeneral Medicinemedicine.diseaseComorbidityCase-Control StudiesPediatrics Perinatology and Child Healthbusiness
researchProduct

The effect of a prenatal lifestyle intervention on glucose metabolism: Results of the Norwegian Fit for Delivery randomized controlled trial

2017

Background: The effectiveness of prenatal lifestyle intervention to prevent gestational diabetes and improve maternal glucose metabolism remains to be established. The Norwegian Fit for Delivery (NFFD) randomized, controlled trial studied the effect of a combined lifestyle intervention provided to a general population, and found significantly lower gestational weight gain among intervention participants but no improvement in obstetrical outcomes or the proportion of large infants. The aim of the present study is to examine the effect of the NFFD intervention on glucose metabolism, including an assessment of the subgroups of normal-weight and overweight/obese participants. Methods: Healthy, …

Adultmedicine.medical_specialtyPopulation030209 endocrinology & metabolismInterventionPrenatal careHealth PromotionOverweightlcsh:Gynecology and obstetricslaw.inventionBody Mass Index03 medical and health sciencesYoung Adult0302 clinical medicineInsulin resistanceRandomized controlled triallawPregnancyDiabetes mellitusInternal medicineMedicineHumans030212 general & internal medicineObesityeducationlcsh:RG1-991Gestational diabeteseducation.field_of_studybusiness.industryNorwayObstetrics and GynecologyPrenatal CareOverweightmedicine.diseaseLifestyleGestational diabetesPregnancy ComplicationsDiabetes GestationalPhysical therapyFemalemedicine.symptomInsulin ResistancebusinessWeight gainResearch Article
researchProduct

Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients

2015

Abstract Objective We aim to assess the effect of metformin treatment on metabolic parameters, endothelial function and inflammatory markers in polycystic ovary syndrome (PCOS) subjects. Methods The study population consisted of 40 reproductive-age women with PCOS, who underwent treatment with metformin during a 12-week period, and their corresponding matched controls (n = 44). We evaluated endocrinological parameters, adhesion molecules (vascular cell adhesion molecule 1 (VCAM-1), intercellular cell adhesion molecule 1 (ICAM-1) and E-selectin) and proinflammatory cytokines (interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα)) in serum. In addition, interactions between human umbili…

Adultmedicine.medical_specialtyTime FactorsAdolescentendocrine system diseasesEndotheliumType 2 diabetesProinflammatory cytokineYoung AdultInsulin resistanceInternal medicineCell AdhesionHuman Umbilical Vein Endothelial CellsLeukocytesmedicineHumansLeukocyte RollingEndothelium Leukocyte Metformin Mitochondria PCOS Type 2 diabetesCells CulturedCell adhesion moleculebusiness.industryEndothelial Cellsnutritional and metabolic diseasesmedicine.diseasePolycystic ovaryCoculture TechniquesMetforminMetforminEndothelial stem cellTreatment Outcomemedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2SpainCytokinesFemaleInflammation MediatorsCardiology and Cardiovascular MedicinebusinessCell Adhesion MoleculesBiomarkersPolycystic Ovary Syndromemedicine.drugAtherosclerosis
researchProduct

Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia

2009

Abstract Background Gestational diabetes mellitus (GDM) is a form of diabetes that occurs during pregnancy. GDM is a well known risk factor for foetal overgrowth, termed macrosomia which is influenced by maternal hypergycemia and endocrine status through placental circulation. The study was undertaken to investigate the implication of growth factors and their receptors in GDM and macrosomia, and to discuss the role of the materno-foeto-placental axis in the in-utero regulation of foetal growth. Methods 30 women with GDM and their 30 macrosomic babies (4.75 ± 0.15 kg), and 30 healthy age-matched pregnant women and their 30 newborns (3.50 ± 0.10 kg) were recruited in the present study. Serum …

Adultmedicine.medical_specialtyTunisiaendocrine system diseasesOffspringPlacentalcsh:Gynecology and obstetricsFetal MacrosomiaReceptor Platelet-Derived Growth Factor betaGrowth factor receptorEpidermal growth factorPregnancyPlacentaDiabetes mellitusInternal medicineResearch articleObstetrics and GynaecologyFetal macrosomiamedicineHumansRNA MessengerInsulin-Like Growth Factor Ilcsh:RG1-991PregnancyEpidermal Growth Factorbusiness.industryInfant NewbornObstetrics and Gynecologynutritional and metabolic diseasesmedicine.diseasefemale genital diseases and pregnancy complicationsUp-RegulationGestational diabetesDiabetes Gestationalmedicine.anatomical_structureEndocrinologyInsulin-Like Growth Factor Binding Protein 3Case-Control StudiesGrowth HormoneIntercellular Signaling Peptides and ProteinsFemaleFibroblast Growth Factor 2businessBMC Pregnancy and Childbirth
researchProduct

Major gender difference in association of FTO gene variant among severely obese children with obesity and obesity related phenotypes.

2008

Recent studies have shown that SNPs in the FTO gene predispose to childhood and adult obesity. In this study, we examined the association between variants in FTO and KIAA1005, a gene that maps closely to FTO, and obesity, as well as obesity related traits among 450 well characterised severely obese children and 512 normal weight controls. FTO showed significant association with several obesity related traits while SNPs in KIAA1005 did not. When stratified by gender, the FTO variant rs9939609 showed association with obesity and BMI among girls (P = 0.006 and 0.004, respectively) but not among boys. Gender differences were also found in the associations of the FTO rs9939609 with obesity relat…

Adultmedicine.medical_specialtyendocrine system diseasesAdolescentmedicine.medical_treatmentBiophysicsAlpha-Ketoglutarate-Dependent Dioxygenase FTOSingle-nucleotide polymorphismBiochemistryFTO genePolymorphism Single NucleotideRisk AssessmentBody Mass IndexInsulin resistanceSex FactorsRisk FactorsInternal medicineDiabetes mellitusmedicinePrevalenceSNPHumansGenetic Predisposition to DiseaseObesitySex DistributionChildMolecular BiologySwedenbusiness.industryInsulinnutritional and metabolic diseasesGenetic VariationProteinspathological conditions signs and symptomsCell Biologymedicine.diseaseObesityEndocrinologyPhenotypeInsulin ResistancebusinessBody mass indexBiochemical and biophysical research communications
researchProduct

Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents

2021

Abstract Aims To analyze therapeutic inertia in type 2 diabetes (T2D) subjects with suboptimal glycemic control and treated with ≥2 non-insulin antidiabetic agents in a primary care setting. Methods A retrospective study was conducted using electronic medical records from subjects with HbA1c ≥7.0% (≥53 mmol/mol). Therapeutic inertia was defined as the absence of treatment intensification despite suboptimal glycemic control where intensification should have been implemented (HbA1c ≥7.5% [≥58 mmol/mol]). Time to the first intensification with non-insulin antidiabetic agent or insulin and HbA1c values at the time of intensification were evaluated by competing risk analysis. Results 2652 adults…

Adultmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentTreatment intensificationInsulins030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsRetrospective StudiesTherapeutic inertiaGlycemicGlycated Hemoglobinbusiness.industryMedical recordInsulinnutritional and metabolic diseasesRetrospective cohort studymedicine.diseaseDiabetes Mellitus Type 2businessJournal of Diabetes and its Complications
researchProduct